Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
Neoadjuvant immunochemotherapy demonstrated high safety and efficacy in oral SCC. CRT was superior to RT in terms of overall survival especially in patients with MPR when administered following neoadjuvant immunochemotherapy and surgery.
Authors
- Qigen Fang (ORCID: https://orcid.org/0000-0002-7303-1030)
- Gang Li (ORCID: https://orcid.org/0000-0003-2144-4631)
- Wei Du (ORCID: https://orcid.org/0000-0002-7410-9194)
- Jiheng Wang (ORCID: https://orcid.org/0000-0002-5556-8731)
- Liyuan Dai (ORCID: https://orcid.org/0009-0007-4848-3709)
Institutions
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1571285
- Citations
- 9
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 9.41